Storia in 8 fonti

Trump announces deal to lower prices for obesity drugs - UPI.com

Eli Lilly and Novo Nordisk officials have agreed to lower the cost of GLP-1 obesity drugs for Medicaid and Medicare recipients and those who pay directly.

Raccontata da

giovedì 6 novembre 2025·ft.com
US to slash prices of obesity drugs offered on Trump website
White House’s landmark deal with Novo Nordisk and Eli Lilly will cut costs from at least $1,000 to about $350
giovedì 6 novembre 2025·forbes.com
Trump Says Obesity Drugmakers Will Cut GLP-1 Prices—Medicare Will Cover Some Costs
The deal also means Medicare will start covering obesity drugs for some patients for the first time beginning next year.

giovedì 6 novembre 2025·

ilsole24ore.com

Trump, accordo per farmaci antiobesità alla portata di tutti

Il presidente, Eli Lilly e Novo Nordisk hanno presentato un accordo per ridurre i prezzi dei popolari farmaci dimagranti Zepbound e Wegovy a base di GLP-1 per i programmi…

giovedì 6 novembre 2025·

cnbc.com

Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage

The deals are among the most politically significant announcements to date in the Trump administration's efforts to rein in high U.S. drug costs.

giovedì 6 novembre 2025·

bbc.com

Trump unveils deals to lower US weight-loss drug prices

US President Donald Trump announces agreements with drug makers Eli Lilly and Novo Nordisk.

giovedì 6 novembre 2025·

fortune.com

Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic | Fortune

America's waistline may shrink, but its national debt will swell.

giovedì 6 novembre 2025·

cnbc.com

Here's how much weight loss drugs could cost you under Trump's deals with Eli Lilly, Novo Nordisk

The monthly out-of-pocket cost of popular injections and upcoming pills could range from $50 to $350, depending on the dosage and insurance coverage.

giovedì 6 novembre 2025·

upi.com